Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$647,582
-$31,271,599 QoQ
Shares Held
20,275
-97.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 169 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Derivatives in TYRA
reported options exposure · as of Jun 30, 2026CallValue
$3,631,578
CallShares
113,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. TYRA ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in TYRA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,631,578 | 113,700 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $647,582 | 20,275 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,919,181 | 833,399 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,006,162 | 76,309 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $799,191 | 57,126 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $589,080 | 61,555 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $395,352 | 42,511 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $598,673 | 43,070 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $884,563 | 37,625 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $200,178 | 12,519 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $161,540 | 9,850 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $266,293 | 19,227 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $34,507 | 2,506 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $47,479 | 2,788 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $109,034 | 6,785 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $27,215 | 3,581 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $4,887 | 556 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $4,704 | 658 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,490 | 1,915 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||